Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 8 projects/programmes

EQIPD

European Quality In Preclinical Data

EU-AIMS

European Autism Interventions - a Multicentre Study for Developing New Medications

Closed IMI1 Psychiatric diseases Autism Tools for predicting/monitoring safety Clinical trial design Stem cells Drug discovery

EU-PEARL

EU patient-centric clinical trial platform

Ongoing IMI2 Diabetes & metabolic disorders Psychiatric diseases Infectious diseases Rare/orphan diseases Clinical trial design Clinical networks Patient involvement in R&D

NEWMEDS

Novel methods leading to new medications in depression and schizophrenia

Closed IMI1 Psychiatric diseases Tools for predicting/monitoring safety Clinical trial design Drug discovery

PRISM

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD

Closed IMI2 Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy Target identification Drug discovery

PRISM 2

Psychiatric ratings using intermediate stratified markers 2

Ongoing IMI2 Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Disease taxonomy Target identification

RADAR-CNS

Remote Assessment of Disease and Relapse in Central Nervous System Disorders

Ongoing IMI2 Psychiatric diseases Pain RADAR Digital health Big data and knowledge management

STEMBANCC

Stem cells for biological assays of novel drugs and predictive toxicology

Closed IMI1 Diabetes & metabolic disorders Psychiatric diseases Stem cells